On Bay Street, you can now buy weed.
Rather, make that “WEED.” Amid what it says is a growing acceptance of Canada’s burgeoning medical-marijuana industry, Canopy Growth Corp., switched to the new four-letter stock ticker on the Toronto Stock Exchange Wednesday.
“We’re thrilled to be marketing WEED on Bay Street,” chief executive officer Bruce Linton said in a statement.
Smiths Falls, Ont.-based Canopy became Canada’s first marijuana unicorn when its market capitalization surpassed $1 billion last year. It currently has a valuation of $1.6 billion. The company has yet to post a net profit, according to data compiled by Bloomberg.
The value of marijuana stocks in Canada has swelled as shareholders bet on the legalization of recreational use. The government has promised to introduce the necessary legislation in 2017, which Matadorbet would make it the first among the G-7 countries to do so.
If legalization occurs along expected timelines, there could be 3.8 million recreational users and the potential for $6 billion of sales, Canaccord Genuity analysts said in a November note.
Canopy shares have more than tripled in the past 12 months.
The Toronto Star and thestar.com, each property of Toronto Star Newspapers Limited, One Yonge Street, 4th Floor, Toronto, ON, M5E 1E6. You can unsubscribe at any time. Please contact us or see our privacy policy for more information.
Our editors found this article on this site using Google and regenerated it for our readers.